ArticleInternational journal of chronic obstructive pulmonary disease2026
Red Cell Distribution Width Predicts Mortality in Critically Ill Patients with COPD and Atrial Fibrillation: A Retrospective Cohort Study.
Article in International journal of chronic obstructive pulmonary disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Critically ill patients with COPD and atrial fibrillation (AF) face a substantially poor prognosis. Given the established prognostic value of red cell distribution width (RDW) in each condition alone, we sought to systematically evaluate its utility for mortality prediction in this population. Methods: This retrospective cohort study utilized data from the MIMIC-IV database. Adult ICU patients with concurrent COPD and AF were enrolled. The association between baseline RDW (analyzed both as a continuous variable and in quartiles) and the primary outcome of in-hospital mortality was assessed using multivariable logistic regression, with extensive adjustment for demographics, severity of illness, comorbidities, and treatments. Secondary outcomes included ICU, 28-day, 90-day, and 1-year all-cause mortality. Results: Among 1,252 eligible patients, a significant graded association was observed between RDW and in-hospital mortality (P for trend < 0.001). After full adjustment, each standard deviation increase in RDW was associated with a 13% rise in the odds of in-hospital death (adjusted OR 1.13, 95% CI 1.05-1.21). Patients in the highest RDW quartile had a 2.53-fold increased risk (adjusted OR 2.53, 95% CI 1.36-4.73) compared to the lowest quartile. This robust association was consistently observed for all secondary outcomes, with the risk of ICU, 28-day, 90-day, and 1-year mortality also showing significant, graded increases across RDW quartiles in the fully adjusted models (all P for trend < 0.01). Furthermore, the association remained stable across all predefined subgroup analyses. Conclusion: In critically ill patients with COPD and AF, elevated baseline RDW at ICU admission is independently associated with increased short- and long-term mortality, with a graded risk increase across RDW quartiles. As a non-specific, routinely available hematologic parameter, RDW may serve as an adjunctive marker for risk stratification in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.